Sectors296 funds · $964B
Top YTD · 20 of 296YTD
Compare tray · 3
SBIOXLVVOO
Compare 3 funds →
Your desk · 0 saved viewsOpen
Save view, at the bottom, keeps this one here
SBIO is #171 of 296 this yearShow all 296

XLV vs SBIO

YTD
XLVSPDRSBIOALPS
Year to date
XLV wins+14.2 pts
Past year
XLV wins+9.3 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV269.5× more
4–0XLV wins
XLV and SBIO · year-to-date · as of Nov 4, 2026 · AUM not scored
@TheETFTracker·theetftracker.com

SBIO vs S&P 500

MAX$54.37 · +1.7% last session
Dividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
0%+200%+137.7%S&P 500 +349.3%Dec 31, 2014Nov 3, 2026
Return1D1M3MYTD1Y3Y5YMAX ▼
Total return+1.7%−3.4%−18.0%+6.1%+20.4%+140.0%+22.4%+137.7%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
ALPS SBIO and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
@TheETFTracker·theetftracker.com

SBIO’s Peers

YTDHealth Care · 6 largest
#Trend
1XLVState Street Health Care Select Sector SPDR ETFReadVersus0.08%1.4%−0.3%+20.4%+29.7%$49.1B
2VHTVanguard Health Care ETFReadVersus0.09%1.4%−0.1%+19.6%+28.1%$19.1B
3XBIState Street SPDR S&P Biotech ETFReadVersus0.35%0.4%+1.9%+27.2%+38.1%$10.5B
4IYHiShares U.S. Healthcare ETFReadVersus0.37%1.0%−0.4%+19.8%+28.6%$4.7B
5IXJiShares Global Healthcare ETFReadVersus0.38%1.3%−0.5%+16.0%+24.7%$4.6B
6SBIOALPS Medical Breakthroughs ETFThis fund0.50%—+1.7%+6.1%+20.4%$182M
#29 of 33 this year · #24 cheapest of 39 · sorted by assetsOpen the Sectors table →
SBIO and its peer group · total return · as of Nov 4, 2026
@TheETFTracker·theetftracker.com

Cards for This View

SBIO’s Top 10 Holdings

Today
31.5%of SBIO sits in these 10
1ORKAOruka Therapeutics4.33%
2CGONCG oncology3.76%
3MANEVeraDermics3.71%
4TVTXTravere Therapeutics3.18%
5DNTHDianthus Therapeutics3.15%
6DFTXDefinium Therapeutics2.99%
7EWTXEdgewise Therapeutics2.84%
8RLAYRelay Therapeutics2.60%
9XENEXenon Pharmaceuticals2.50%
10ACADACADIA Pharmaceuticals2.42%
ALPS SBIO · weight in the fund · as of Nov 3, 2026
@TheETFTracker·theetftracker.com

XLV vs SBIO

YTD
XLVSPDRSBIOALPS
Year to date
XLV wins+14.2 pts
Past year
XLV wins+9.3 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV269.5× more
4–0XLV wins
XLV and SBIO · year-to-date · as of Nov 4, 2026 · AUM not scored
@TheETFTracker·theetftracker.com

SBIO vs Peer Average

YTD
SBIOAvsBPeer average
1D+1.7%+0.6%
1M−3.4%+4.0%
3M−18.0%+6.1%
YTD+6.1%+21.0%
1Y+20.4%+29.0%
3Y+140.0%+81.2%
5Y+22.4%+28.9%
2–5Peer average wins
38 Health care peers · each row scaled to its leader
@TheETFTracker·theetftracker.com